Stable, recombinant ValiScreen® cell line expressing the Nicotinic receptor 1 (GPR109A, HM74A), human recombinant in CHO-K1 host cells.
Revvity's ValiScreen® cell lines are provided in two vials of frozen cells, each containing ∽2.5 x 106 cells. Detailed product information as well as recommended cell culture conditions and validation assay date are available each cell line.
Clonal selection Revvity's ValiScreen cell lines is carried out with receptor binding. High and low expressors are n tested and selected optimal binding and functional response according to receptor specific transduction pathway.
Revvity's ValiScreen cell lines require accepted cell line Terms and Conditions prior to order processing. Additional agreement needed commercial use. Contact us using Request More Information button above additional information regarding required documentation.
Assay Validation |
Binding
cAMP
GTPγS
|
---|---|
Assay Target Class |
GPCR
|
Assay Target Type |
Cell line
|
Brand |
ValiScreen
|
G-Alpha Natural Receptor |
Gi/Go
|
Host |
CHO-K1
|
Receptor Type |
Nicotinic
|
Second Messenger Release |
GTP exchange
|
Shipping Conditions |
Shipped in Dry Ice
|
Special Ordering Information |
Requires accepted Terms and Conditions. Additional agreement needed for commercial use.
|
Therapeutic Area |
Central Nervous System
Inflammation
Pain
|
Unit Size |
5 million cells
|